FDA Approved: CATHFLO ACTIVASE — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cathflo Activase (alteplase) from Genentech, resulting in labeling/indication changes for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Venous Catheter Occlusion
• Venous Thrombosis

Drugs mentioned

• CATHFLO ACTIVASE (ALTEPLASE)

Snippet

SUPPL AP for CATHFLO ACTIVASE (ALTEPLASE)